TIL - Instil Bio GAAP EPS of -$0.41 in-line

2023-03-31 09:19:44 ET

• Instil Bio press release ( NASDAQ: TIL ): Q4 GAAP EPS of -$0.41 in-line.
• As of December 31, 2022, Instil had $260.9 million in total cash and cash equivalents and marketable securities, comprised of $43.7 million in cash and cash equivalents and $217.2 million in marketable securities, compared to $454.1 million in total cash and cash equivalent and marketable securities, comprised of $37.6 million in cash and cash equivalents and $416.5 million in marketable securities, as of December 31, 2021.
• Instil expects that its cash, cash equivalents and marketable securities as of December 31, 2022 will enable it to fund its operating plan beyond 2026.

For further details see: